The Cancer Precision Medicine Commons is a place for organization leaders to share information and explore opportunities for cross-tumor collaborations.
Our goal is to increase knowledge about, access to, and appropriate use of the latest oncology precision medicine tools.
DECEMBER 2, 2026
CPMC Q4 Meeting: AI and the Future of Patient Education in Precision Oncology
How is AI changing the way patients learn about biomarker and genetic testing? Join CPMC on Tuesday, December 2, from 1-2 PM ET, for a conversation on the opportunities and challenges of using AI to improve patient understanding, support shared decision-making, and navigate the rapidly evolving landscape of precision oncology.
Moderator: Roxanne Jensen, PhD, Outcomes Research Branch of the Healthcare Delivery Research Program, National Cancer Institute
Speakers
- Dr. Eric Singhi, Oncologist, MD Anderson Cancer Center
- Dr. Jason Wasserman, Pathologist, University of Ottawa & Founder, MyPathologyReport
- Sanjay Juneja, Tempus AI
Share Your Model for Equitable Access to Genetic & Biomarker Testing
Are you leading a program that can help inform best practices and support cross-disease collaboration in cancer care?
Cancer Biomarker Awareness Day
Join us for a cross-cancer, nationwide recognition of the critical role biomarker testing plays in enabling access to precision medicine.
The CPMC hosts three dedicated working groups.
Addressing barriers, promoting best practices, and development and encouragement.
The CPMC provides a forum for information and resource sharing.
With the rapid pace of scientific discovery, there is a continuing need to identify and fill gaps in the knowledge about, access to, and appropriate use of the latest oncology precision medicine tools.
